Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer

BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors prevent cell growth and have shown benefit in the treatment of metastatic colorectal cancer, whether used as single agents or in combination with chemotherapy. Clear benefit has been shown in trials of EGFR monoclonal antibodies (EGFR MA...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cochrane Database Syst Rev
Glavni autori: Chan, David Lok Hang, Segelov, Eva, Wong, Rachel SH, Smith, Annabel, Herbertson, Rebecca A, Li, Bob T., Tebbutt, Niall, Price, Timothy, Pavlakis, Nick
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2017
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6481896/
https://ncbi.nlm.nih.gov/pubmed/28654140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007047.pub2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items